Carisma Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MERCK & CO., INC. | 11/12/2025 | 1.47 M | $403.67 K | 0.00% | 3.53% |
| VANGUARD GROUP INC | 11/07/2025 | 350.32 K | $95.99 K | 0.00% | 0.84% |
| BLACKROCK, INC. | 11/12/2025 | 336.79 K | $92.28 K | 0.00% | 0.81% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 293.69 K | $80.47 K | -10.81% | 0.70% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 250.50 K | $68.65 K | 0.00% | 0.60% |
| STATE STREET CORP | 11/14/2025 | 85.11 K | $23.32 K | 0.00% | 0.20% |
| NORTHERN TRUST CORP | 11/14/2025 | 55.04 K | $15.08 K | 0.00% | 0.13% |
| GTS SECURITIES LLC | 11/14/2025 | 50.12 K | $13.73 K | 0.00% | 0.12% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 30.99 K | $8.49 K | 0.00% | 0.07% |
| EMPOWERED FUNDS, LLC | 11/13/2025 | 30.99 K | $8.49 K | 0.00% | 0.07% |
| BLODGETT WEALTH ADVISORS, LLC | 10/28/2025 | 24.00 K | $6.58 K | 0.00% | 0.06% |
| VIRTU FINANCIAL LLC | 11/14/2025 | 22.85 K | $6.00 K | 100.00% | 0.05% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 16.41 K | $4.50 K | 25.98% | 0.04% |
| DYNAMIC FINANCIAL GROUP | 10/28/2025 | 15.35 K | $4.21 K | 0.00% | 0.04% |
| TWO SIGMA SECURITIES, LLC | 11/14/2025 | 12.83 K | $3.52 K | -28.54% | 0.03% |
| CITIGROUP INC | 11/10/2025 | 11.27 K | $3.09 K | 100.00% | 0.03% |
| UBS GROUP AG | 11/13/2025 | 7.03 K | $1.93 K | -68.19% | 0.02% |
| MORGAN STANLEY | 11/14/2025 | 3.19 K | $873 | 0.00% | 0.01% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 2.23 K | $611 | 0.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.40 K | $383 | 4.72% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 921 | $252 | 0.00% | 0.00% |
| UNION BANCAIRE PRIVEE, UBP SA | 10/07/2025 | 535 | $131 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 347 | $95 | 0.00% | 0.00% |
| IFP ADVISORS, INC | 12/02/2025 | 206 | $57 | 0.00% | 0.00% |
| ORG PARTNERS LLC | 10/24/2025 | 200 | $54 | 0.00% | 0.00% |
| CAROLINA WEALTH ADVISORS, LLC | 10/07/2025 | 150 | $41 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 142 | $29 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 107 | $29 | -18.94% | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 11/14/2025 | 50 | $13 | 0.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 11/12/2025 | 37 | $10 | 0.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 16 | $5 | 0.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BAADER BANK AKTIENGESELLSCHAFT | 11/06/2025 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| AJU IB INVESTMENT CO., LTD. | 11/06/2025 | 0 | $0 | -100.00% | 0.00% |
| BANK & TRUST CO | 10/06/2025 | 0 | $0 | -100.00% | 0.00% |
Carisma Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 39 institutional investors and hedge funds held shares of Carisma Therapeutics, Inc.. The most heavily invested institutionals were:
Merck & Co., Inc.: 1.47 M
VANGUARD GROUP INC: 350,324
BlackRock, Inc.: 336,789
RENAISSANCE TECHNOLOGIES LLC: 293,686
GEODE CAPITAL MANAGEMENT, LLC: 250,495
STATE STREET CORP: 85,106
7.36% of Carisma Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 5.08 M shares in the last 24 months. This purchase volume represents approximately $1.33 M in transactions.